Related Experiment Video

Updated: Jun 15, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Administration of influenza vaccines to patients with egg allergy

John M Kelso

    The Journal of Allergy and Clinical Immunology
    |March 16, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Influenza Virus Propagation in Embryonated Chicken Eggs
    06:56

    Influenza Virus Propagation in Embryonated Chicken Eggs

    Published on: March 19, 2015

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
    08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    Published on: July 26, 2019

    Related Experiment Videos

    Last Updated: Jun 15, 2026

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    Influenza Virus Propagation in Embryonated Chicken Eggs
    06:56

    Influenza Virus Propagation in Embryonated Chicken Eggs

    Published on: March 19, 2015

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
    08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    Published on: July 26, 2019

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Cross-reactivity00:42

    Cross-reactivity

    Overview
    Allergic Reactions: Anaphylaxis01:30

    Allergic Reactions: Anaphylaxis

    Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
    Allergic Reactions02:06

    Allergic Reactions

    Overview

    Articles linked to this work by shared authors, journal, and citation graph.

    Safety and Feasibility of Peanut, Tree Nut, and Sesame Oral Immunotherapy in Infants and Toddlers in a Real-World Setting.

    The journal of allergy and clinical immunology. In practice·2024

    Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols.

    The journal of allergy and clinical immunology. In practice·2023

    Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.

    The Journal of allergy and clinical immunology·2023

    Anaphylaxis: Revision of the Brighton collaboration case definition.

    Vaccine·2022

    The adverse reactions to vaccines practice parameter 10 years on-what have we learned?

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2022

    The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.

    The journal of allergy and clinical immunology. In practice·2021

    Pumping the brakes: immune checkpoints as regulators of immunity and targets of cancer therapy.

    The Journal of allergy and clinical immunology·2026

    Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.

    The Journal of allergy and clinical immunology·2026

    Barzolvolimab blocks SCF-enhanced IgE activation without inducing apoptosis in KIT-D816V mast cells.

    The Journal of allergy and clinical immunology·2026

    Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis.

    The Journal of allergy and clinical immunology·2026

    Cadherin-26 Contributes to Intraepithelial Eosinophil and Neutrophil Infiltration in Chronic Rhinosinusitis with Nasal Polyps.

    The Journal of allergy and clinical immunology·2026

    The IL-9R/Arg1 pathway promotes polyamine metabolism in human airway macrophages.

    The Journal of allergy and clinical immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us